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Evidence is presented that expression of the two myelin-associated glycoprotein mRNAs is developmentally regulated 
in mouse brain. In quaking mouse, the mRNA without a 45-nucleotide exon portion was scarcely expressed throughout 
development. We conclude that the mechanism of splicing out the 45-nucleotide exon portion is lacking in quaking 
mouse. 
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1. INTRODUCTION 
The myelin-associated glycoprotein (MAG), a 
glycoprotein with a molecular mass of about 
100 kDa, is a quantitatively minor component of 
central nervous system myelin, but is believed to 
play an important role in oligodendrocyte-axon in- 
teractions [l]. In vitro translation revealed two 
developmentally regulated polypeptides with 
molecular masses of 72 and 67 kDa, respectively 
[2], which are supposed to correspond to the two 
forms of mRNA clarified recently by cDNA clon- 
ing [3,4]. The two forms of rat MAG mRNA are 
produced by alternative splicing of a 45-nucleotide 
(nt) exon portion that contains a termination 
codon [3,4]. 
Quaking mouse is a mutant with impaired 
myelination [5], the mutation being located on 
chromosome 17 [a]. Early fucose-labeling ex- 
periments uggested anomalies of MAG in quaking 
mouse [7]. It was particularly noted that MAG in 
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quaking mouse has a higher molecular mass than 
that in the normal control. In vitro translation with 
mRNA from quaking mouse, however, produced 
mainly a polypeptide at the same position in SDS- 
polyacrylamide gel electrophoresis as the smaller 
polypeptide that was normally found in older 
animals [S] . 
A cDNA of mouse MAG was isolated here and 
sequenced, and two synthetic probes were 
prepared to distinguish the two forms of mouse 
MAG mRNA. Evidence is presented that expres- 
sion of the two forms of MAG mRNA is 
developmentally regulated in mouse brain. One 
form of mRNA had a peak in expression at the 
time of most active myelination and the other form 
had a peak at a later stage of development. In 
quaking mouse, only the latter form of mRNA was 
expressed throughout development; developmen- 
tally regulated alternative splicing of MAG mRNA 
is thus lacking in quaking mouse. 
2. MATERIALS AND METHODS 
Quaking mouse was obtained from Jackson Laboratory (Bar 
Harbor, ME, USA). 
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I Probe 45 0 
Probe 25 : : 
c3 
GCC TAT CCC CAG GAC AAC CGC ACG GTG GAG CTG AGT GTC ATG TAT GCA CCT TGG AAG CCC ACA GTG AAT 
Ala Tyr Gly Gln Asp Asn Arg Thr Val Glu Leu Ser Val Met Tyr Ala Pro Trp Lys Pro Thr Val Asn 
GGG ACG GTG GTG GCi GTA GAG GGG GAG Ati GTC TCi ATC CTG TGT TCC ACA CAG AGC AAC CCC GAC CCC 
Gly Thr Val Val Ali Val Glu Gly Glu Thr Val Ser Ile Leu Cys Ser Thr Gln Ser Asn Pro Asp Pro 
ATC CT-f ACC ATC TTC AAG GAG AAG CAG ATC CTA GCC ACG GTC ATC TAT GAG AGT CAG 
Ile Leu Thr Ile Phe Lys Glu Lys Gln Ile Leu Ala Thr Val Ile Tyr Glu Ser Gln 
C 
Probe 45 AGG TCT c~c CAG AGA TGG GCC CTA ACA GTG ACT CTC GGG GTC CTC 5' 
?.'.GGG GCA CCT GAT AAG TAT GAG TCC AGA GAG GTC TCT ACC CGG GAT TGT CAC TGA GAG CCC CAG GAG AGT GAG AAG $; CGC CTG... 
. ..Gly Ala Pro Asp Lys Tyr Glu Ser Ar Glu Val Ser Thr Ar Asp C s His l ** , ,elSer Glu Lys Gl,n Arg Leu... 
I 1 1 I 
Probe 25 GA CTA TTC ATA CTC TCA CTC TTC GT~' 
Fig.1. Mouse MAC cDNA and probes. (a) Restriction map of mouse MAC cDNA. The region sequenced is shadowed. The positions 
of the probe sequences are indicated under the restriction map. (b) Sequence of the 195nt cDNA.The sequence is completely identical 
with that of rat MAC cDNA except for the 7 nucleotides indicated by dots. (c) Sequence of the 45nt exon and adjacent portions. 
The sequence is completely identical with that of rat MAC cDNA except for the 3 nucleotides indicated by dots. Probe 45 is 
complementary to the sequence of the 45nt exon portion; probe 25 is complementary to the sequences of both sides adjacent o the 
45-nt exon portion. 
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A cDNA library (Agtl 1) for mouse brain was obtained from 
Clontech Laboratories (Palo Alto, CA, USA) and screened with 
anti-mouse MAG serum as described [9]. Anti-mouse MAC 
serum was prepared and characterized as described previously 
for anti-rat MAG serum [lo]. The cDNA was subcloned into 
pSPT18. DNA sequence was determined by the procedure of 
Maxam and Gilbert [I 11. 
Synthetic DNA probes (probe 45 and probe 25) were 
prepared by solid-phase synthesis on an Applied Biosystems 
DNA synthesizer. The purified probes were labeled at the 
5’-end with [y-32P]ATP by Tb polynucleotide kinase [12]. The 
195nt cDNA probe (fig.lb) was labeled with [cu-“P]dCTP by 
a random-primed DNA labeling kit (Boehringer Mannheim, 
Mannheim, FRG). 
Total RNA was prepared by the guanidinium thio- 
cyanate/cesium chloride procedure [13]; poly(A)+ RNA was 
isolated by oligo(dT)-cellulose chromatography [14]. For Nor- 
thern blot analysis, poly(A)+ RNA was subjected to elec- 
trophoresis on a 1.5% agarose gel containing 2.2 M 
formaldehyde, and transferred by capillary blotting to 
nitrocellulose filters. A Bio-Dot SF blotting apparatus (Bio-Rad 
Laboratories, Richmond, CA, USA) was used for slot-blot 
analysis of total RNA. RNA was denatured in 2.2 M for- 
maldehyde at 60°C for 10 min before electrophoresis or slot- 
blotting. 
Filters were hybridized with the cDNA probe or with probe 
45 under the conditions described [15]. Filters were hybridized 
with probe 25 for 20 h at 60°C in 0.9 M NaCl, 0.09 M Tris-HCl 
(pH 7.5), 6 mM EDTA, 0.02% Ficoll, 0.02% prWinYlpyr- 
rolidone, 0.02% bovine serum albumin and 0.1% SDS. They 
were washed twice for 20 min each at 65°C in 0.9 M NaCl, 
0.09 M sodium citrate @H 7.0) and 0.1% SDS, and exposed to 
an X-ray film with an intensifying screen at -70°C. For 
reprobing, the filters were washed twice for 1 h each in 0.05% 
sodium pyrophosphate, 5 mM Tris-HCl (PH 7.5) and 0.2 mM 
EDTA at 70°C. 
3. RESULTS AND DISCUSSION 
One positive clone containing approx. 1350-nt 
cDNA (fig.la) was isolated from a mouse brain 
cDNA library by immunoscreening. The se- 
quenced 1020 nt of the cDNA had 96% identity 
with the corresponding region of the previously 
reported rat MAG cDNA. Two forms of rat MAG 
mRNA are produced by alternative splicing of a 
45-nt exon portion [3,4]. The 45-nt exon portion of 
the mouse MAG cDNA was identical with that of 
the rat MAG cDNA. To distinguish the two forms 
of mouse MAG mRNA, we prepared two synthetic 
probes (fig.lc). Probe 45 is complementary to the 
sequence of the 45-nt exon portion and specific for 
the mRNA which contains the 45-nt exon portion. 
Fig.2. Slot-blot analysis of MAG mRNA in the normal mouse. Total RNA (15 /rg each in I and 40 pg each in II) from 1, 5, 10, 15, 
25, 40-day-old and adult (A) ddY mouse brain was blotted; total RNA from adult ddY mouse liver (L) was also blotted. The filter 
was probed first with probe 25 (b), second with probe 45 (c), and finally with the 195-nt cDNA probe (a). 
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Probe 25 is complementary to the sequences of 
both sides adjacent to the 45-nt exon portion and 
specific for the mRNA which does not contain the 
45-nt exon portion. The 195-nt cDNA probe 
(fig.lb) was used to estimate both forms of MAG 
mRNA. 
The MAG cDNA hybridized at approx. 2500 nt 
in Northern blots of both poly(A)+ RNA and total 
RNA. The developmental changes of MAG 
mRNAs in normal mouse brain were examined by 
slot-blot hybridization of total RNA using the two 
synthetic probes and the cDNA probe (fig.2). 
Probe 25 had a peak in mRNA expression at 15 
days postpartum (fig.ab), probe 45 at 40 days 
(fig.2c), and the cDNA probe had two peaks at 15 
and 40 days (fig.2a). These results indicate that ex- 
pression of the two MAG mRNAs in normal 
mouse brain is developmentally regulated: one 
form of mRNA without the 45-nt exon portion is 
expressed mainly at the time of most active 
myelination, while the other form containing the 
45-nt exon portion is expressed mainly in later 
stages. 
The developmental changes of MAG mRNAs in 
quaking mouse were examined by Northern blot 
analysis (fig.3). In quaking mouse, little hybridiza- 
tion occurred with probe 25 throughout develop- 
ment (fig.3b). Probe 45 and the cDNA probe 
hybridized more intensely in quaking mouse than 
in the control (fig.3a,c). Slot-blot analysis of total 
RNA gave the same results. The results indicate 
that the mRNA without the 45-nt exon portion is 
scarcely expressed in quaking mouse. The other 
form of mRNA containing the 45-nt exon portion 
was over-expressed in quaking mouse. We con- 
clude that the mechanism of splicing out the 45-nt 
exon portion is lacking in quaking mouse. 
This study together with the previous in vitro 
translation analysis [8] suggest that the MAG in 
the brain of quaking mouse consists mainly of the 
smaller polypeptide produced by the mRNA con- 
taining the 45-nt exon portion. The MAG in quak- 
ing mouse is known to have a higher molecular 
mass than that in normal mouse [7]. This is 
probably due to the difference in the carbohydrate 
portion of the MAG molecule. It should be noted 
that the amount of MAG is greatly reduced in the 
brain of quaking mouse [ 161 though the mRNA for 
the smaller polypeptide is over-expressed. 
The fact that the MAG mRNA without the 45-nt 
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Fig.3. ‘Northern blot analysis of MAG mRNA in quaking 
mouse. Poly(A)+ RNA (6pg each) from 15, 25day-old and 
adult (A) quaking mouse brain was electrophoresed. Poly(A)+ 
RNA (6pg each) from 25day-old and adult (A) ddY mouse 
brain was also electrophoresed. The filter was probed first with 
probe 25 (b), second with probe 45 (c), and finally with the 
195~nt cDNA probe (a). 
exon portion is expressed mainly at the time of 
most active myelination suggests that the 
mechanism of splicing out the 45-nt exon in the 
early stage of development is important for 
myelination. We suppose that deficiency of this 
mechanism is involved in the pathogenesis of 
quaking mouse. D’Eustachio et al. [17] have 
recently shown that the MAG coding sequence 
Volume 232, number 2 FEBS LETTERS May 1988 
resides on chromosome 7; thus the genetic locus of 
MAG is different from that of the quaking muta- 
tion. It is unknown how the quaking mutation 
causes the abnormal MAG mRNA expression 
described here. 
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